Video Abstract.mp4 (19.6 MB)View fileThis item contains files with download restrictions
Next page
Previous page
1/1
Switch ViewSwitch between different file views
Thumbnail viewList viewFile view
4 filesFullscreen
Real-World Evidence for Control of Chronic Migraine Patients Receiving CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA: A Retrospective Chart Review
Version 6 2021-10-20, 09:37Version 6 2021-10-20, 09:37
Version 5 2021-10-15, 13:18Version 5 2021-10-15, 13:18
Version 4 2021-10-15, 13:15Version 4 2021-10-15, 13:15
Version 3 2021-10-15, 08:14Version 3 2021-10-15, 08:14
Version 2 2021-04-21, 15:42Version 2 2021-04-21, 15:42
Version 1 2021-04-15, 16:19Version 1 2021-04-15, 16:19
media
posted on 2021-10-20, 09:37authored byAdis journalson behalf of, Andrew M Blumenfeld, Benjamin M Frishberg, Jack D Schim, Ashley Iannone, Gary Schneider, Larisa Yedigarova, Aubrey Manack Adams
Article full
text
The article associated with this page
has been accepted for online publication and is in the final stages of
production. The link to the full text will be made available on this page in
the next few days.
The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).